Li Li
About Li Li
Li Li is the Principal Scientist and Head of Cell and Molecular Biology at Alkermes, with extensive experience in neuroscience and drug discovery from institutions including the Broad Institute of MIT and Harvard, Galenea, and Pfizer.
Current Role at Alkermes
Li Li is currently serving as Principal Scientist and Head of Cell and Molecular Biology at Alkermes in Waltham, MA. In this role, Li leads research initiatives focusing on cell and molecular biology, contributing to the company's drug discovery and development processes. Responsibilities include overseeing laboratory activities, guiding research projects, and collaborating with cross-functional teams to advance drug candidates from discovery to preclinical development.
Previous Experience at Broad Institute of MIT and Harvard
Li Li worked at the Broad Institute of MIT and Harvard from 2014 to 2018, initially as a Senior Research Scientist and later as Research Scientist II. Additionally, Li held the position of Vice Chair and Lunch Chair for the Staff Scientist Development Committee from 2016 to 2018. During this period, Li contributed significantly to neurodegenerative disease research and drug discovery projects, presenting findings at international conferences like the Society for Neuroscience Annual Meeting.
Experience at Galenea and Pfizer
Before joining the Broad Institute, Li Li worked at Galenea as a Scientist/Associate Scientist from 2012 to 2014. Prior to that, Li was a Postdoctoral Fellow at Pfizer from 2010 to 2012, where he conducted research in molecular biology and neuroscience. These roles involved developing and implementing high-throughput screening assays for drug discovery projects and mentoring junior scientists and postdoctoral fellows.
Academic Background
Li Li holds a Ph.D. in Neuroscience from the University of Wisconsin-Madison, completed between 2004 and 2010. Li also has a B.S. in Biosciences from the University of Science and Technology of China, where he studied from 2000 to 2004. Additionally, Li completed an Introduction to Regulatory Affairs for Biotech Professionals program at the Harvard Extension School in 2013.
Research Contributions and Publications
Li Li has published multiple peer-reviewed articles on neurodegeneration and psychiatry drug discovery. These publications have contributed to the scientific community's understanding of the molecular mechanisms underlying neurodegenerative diseases. Li also received a grant from the National Institutes of Health (NIH) for research on these mechanisms and has presented research findings at prominent international conferences.